US Patent 7361752 RNAi modulation of MLL-AF4 and uses thereof
Patent 7361752 was granted and assigned to Alnylam Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7361752 RNAi modulation of MLL-AF4 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.